Company Number: 13910673

Analysis Date: 2025-07-20 13:48 UTC

1. Credit Opinion: DECLINE
   SUPREMUS MEDITECH GLOBAL LIMITED is a dormant company with no trading activity or financial transactions reported since incorporation in February 2022. The financials show zero net assets, zero cash, and no revenue or expenses. There is no evidence of operating performance, cash generation, or financial resilience. The company has not demonstrated any capacity to service debt or fulfill commercial obligations. Without trading history or financial strength, extending credit would be high risk.

2. Financial Strength:
   The balance sheet is effectively nil with net assets and shareholders’ funds of £0.03, reflecting only nominal share capital. There are no fixed or current assets, no cash reserves, and no liabilities. This indicates the company has not commenced operational activities or invested capital beyond initial formation. The financial position does not support any borrowing or financial commitments.

3. Cash Flow Assessment:
   There is no cash flow to assess as the company has no reported income, expenses, or cash balances. The company is dormant, so working capital and liquidity are nil. This lack of liquidity means the company cannot meet any short-term obligations or sustain operations without new capital injections.

4. Monitoring Points:

• Commencement of trading and revenue generation.
• Filing of full accounts with financial statements showing assets, liabilities, and profitability.
• Changes in cash balances and evidence of working capital management.
• Director changes and any shifts in ownership or control that might affect credit risk.
• Any indication of external funding or capital raising to support operations.